PMV Pharmaceuticals, Inc.
General ticker "PMVP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $65.5M (TTM average)
PMV Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 10.6%.
Estimated limits based on current volatility of 2.4%: low 1.17$, high 1.23$
Factors to consider:
- Total employees count: 47 (-25.4%) as of 2024
- Top business risk factors: Limited operating history, Commercialization challenges, Geopolitical risks, Market competition, Regulatory and compliance
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.96$, 2.50$]
- 2026-12-31 to 2027-12-31 estimated range: [0.96$, 2.48$]
Financial Metrics affecting the PMVP estimates:
- Positive: with PPE of -0.8 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 109.29 > -0.60
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term PMVP quotes
Long-term PMVP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $80.13MM | $85.45MM | $86.21MM |
| Operating Income | $-80.13MM | $-85.45MM | $-86.21MM |
| Non-Operating Income | $11.17MM | $10.64MM | $6.29MM |
| R&D Expense | $55.88MM | $58.53MM | $69.88MM |
| Income(Loss) | $-68.96MM | $-74.81MM | $-79.91MM |
| Taxes | $0.00MM | $-16.10MM | $-2.17MM |
| Net Income(Loss)* | $-68.96MM | $-58.71MM | $-77.74MM |
| Stockholders Equity | $225.69MM | $176.08MM | $104.71MM |
| Assets | $252.15MM | $191.29MM | $116.56MM |
| Operating Cash Flow | $-55.66MM | $-51.28MM | $-73.58MM |
| Capital expenditure | $0.96MM | $0.66MM | $0.03MM |
| Investing Cash Flow | $-50.55MM | $53.35MM | $70.17MM |
| Financing Cash Flow | $35.58MM | $0.31MM | $0.51MM |
| Earnings Per Share** | $-1.44 | $-1.14 | $-1.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.